Alnylam Pharmaceuticals (ALNY) Exchange Rate Effect (2019 - 2026)
Alnylam Pharmaceuticals (ALNY) has disclosed Exchange Rate Effect for 9 consecutive years, with -$7.1 million as the latest value for Q1 2026.
- For Q1 2026, Exchange Rate Effect fell 150.25% year-over-year to -$7.1 million; the TTM value through Mar 2026 reached $13.8 million, up 57.69%, while the annual FY2025 figure was $34.9 million, 329.25% up from the prior year.
- Exchange Rate Effect hit -$7.1 million in Q1 2026 for Alnylam Pharmaceuticals, down from -$5.7 million in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $27.5 million in Q2 2025 and bottomed at -$17.3 million in Q4 2024.
- Average Exchange Rate Effect over 5 years is $682000.0, with a median of -$927000.0 recorded in 2025.
- Year-over-year, Exchange Rate Effect tumbled 2300.0% in 2024 and then skyrocketed 981.6% in 2025.
- Alnylam Pharmaceuticals' Exchange Rate Effect stood at $1.6 million in 2022, then skyrocketed by 573.07% to $10.9 million in 2023, then tumbled by 258.49% to -$17.3 million in 2024, then soared by 66.99% to -$5.7 million in 2025, then decreased by 23.91% to -$7.1 million in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods came in at -$7.1 million, -$5.7 million, and -$927000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.